Week in review: COVID candidate, new Quest, dopamine boost
- Posted on: Sep 18 2020
- Leave a response
This week, Aldeyra Therapeutics gets clearance to test their drug for COVID-19, Oculus announces the new and improved Quest 2 VR headset and a common Parkinson drug shows promise for AMD.
Source: AAO
Posted in: Uncategorized
